Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Core Scientific (CORZ) Shares Outstanding (2020 - 2026)

Core Scientific has reported Shares Outstanding over the past 7 years, most recently at $316.9 million for Q1 2026.

  • Quarterly results put Shares Outstanding at $316.9 million for Q1 2026, up 5.97% from a year ago — trailing twelve months through Mar 2026 was $316.9 million (up 5.97% YoY), and the annual figure for FY2025 was $314.2 million, up 7.39%.
  • Shares Outstanding reached $316.9 million in Q1 2026 per CORZ's latest filing, up from $314.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $386.9 million in Q4 2023 and bottomed at $182.2 million in Q1 2024.
  • Median Shares Outstanding over the past 5 years was $316.9 million (2026), compared with a mean of $319.5 million.
  • The largest annual shift saw Shares Outstanding skyrocketed 123.97% in 2022 before it tumbled 51.77% in 2024.
  • Over 5 years, Shares Outstanding stood at $375.2 million in 2022, then rose by 3.11% to $386.9 million in 2023, then dropped by 24.37% to $292.6 million in 2024, then rose by 7.39% to $314.2 million in 2025, then grew by 0.86% to $316.9 million in 2026.
  • Business Quant data shows Shares Outstanding for CORZ at $316.9 million in Q1 2026, $314.2 million in Q4 2025, and $308.4 million in Q3 2025.